Every SEC Form 3/4/5 on record for this filer (CIK 1730171) — 2 issuers, 2 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| NVNO | enVVeno Medical Corp | SVP & Chief Medical Officer | 2021-12-02 → 2025-12-18 | 4 | — |
| HJLI | Hancock Jaffe Laboratories, Inc. | SVP & Chief Medical Officer · lapsed | 2018-05-30 → 2021-05-25 | 5 | $9,440 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| HJLI | 2021-05-21 | Buy | 1,600 | $5.90 | $9,440 | 1,600 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.